Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

NCT03658629 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1375

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated 182 days after initial dosing.

Conditions

Influenza, Human

Interventions

BIOLOGICAL: NanoFlu (Quad-NIV)
OTHER: Matrix-M Adjuvant
OTHER: Placebo
BIOLOGICAL: Fluzone HD
BIOLOGICAL: Flublok Quadrivalent
BIOLOGICAL: Influenza Vaccine

Sponsor

Novavax